DRKS00029553已完成不适用
Medical management of CNS hemangioblastoma in pediatric patients with von Hippel-Lindau (VHL) disease
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 99
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 1 Years 至 18 Years（—）
- 性别
- All
入选标准
- •Pediatric patients diagnosed with VHL disease and available MRI examinations of the CNS during the period 01/2000 - 07/2022
排除标准
- •Presence of sporadic CNS hemangioblastoma (thus excluding VHL disease).
- •Presence of MRI examinations exclusively in adulthood.
研究者
相似试验
尚未招募
不适用
Management of spinal hemangioblastomaD33.4Spinal cordDRKS00033224niversitätsklinikum Freiburg200
进行中（未招募）
不适用
Tratamiento de los hemangiomas de la infancia con imiquimod tópico al 5%EUCTR2004-001262-40-ESInvestigador del estudio: Dr. Agustín Alomar Muntañola
已完成
不适用
ational Survey of Hemangioblastoma Using Brain Tumor Registory of JapaHemangioblastomaJPRN-UMIN000045967Shimane Prefectural Central Hospital443
招募中
不适用
Response-based treatment of high-risk neuroblastomaNeoplasmsKCT0002038Samsung Medical Center54
未知
3 期
M703101 phase III study with infantile hemangiomasInfantile HemangiomasJPRN-jRCT2080222409Maruho Co.,Ltd.